Nuwellis, Inc. To Announce Second Quarter 2021 Financial Results on August 10, 2021
Nuwellis, Inc. (NASDAQ: NUWE) will announce its second quarter 2021 financial results on August 10, 2021, at 9:00 AM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nuwellis, Inc. (NASDAQ: NUWE) will announce its second quarter 2021 financial results on August 10, 2021, at 9:00 AM ET. Following the release, management will host a conference call and webcast to discuss the company's performance and provide a business overview. Interested parties can access the live discussion via the Nuwellis Investors page or by phone. The company specializes in developing the Aquadex SmartFlow® system for ultrafiltration therapy, aimed at helping patients with fluid overload.
Details
News Market Reaction – NUWE
The recorded move for NUWE in the trading session of this news was +0.50%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., July 27, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), announced today that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview.
To access the live webcast, please visit the Investors page of the Nuwellis website at http://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 1396749. An audio archive of the webcast will be available following the call on the Investor page at http://ir.nuwellis.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq:NUWE) is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, Minn., with a wholly-owned subsidiary in Ireland. The Company has been listed on the Nasdaq Capital Market since February 2012, previously branded as CHF Solutions (Nasdaq:CHFS).
CONTACTS
INVESTORS:
George Montague
Chief Financial Officer, Nuwellis, Inc.
ir@nuwellis.com
Matt Bacso, CFA
Gilmartin Group LLC
Matt.bacso@gilmartinir.com
MEDIA:
Jessica Stebing
Health+Commerce
jstebing@healthandcommerce.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.